Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG)
- 17 March 2004
- journal article
- Published by Elsevier
- Vol. 84 (1) , 43-49
- https://doi.org/10.1016/0304-3835(94)90356-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Distribution of disulfonated and tetrasulfonated aluminum phthalocyanine between malignant and host cell populations of a murine fibrosarcomaJournal of Photochemistry and Photobiology B: Biology, 1993
- Can PDT be potentiated by immunotherapy?Published by SPIE-Intl Soc Optical Eng ,1993
- Host cell infiltration into PDT-treated tumorPublished by SPIE-Intl Soc Optical Eng ,1992
- Distribution of Photofrin between tumour cells and tumour associated macrophagesBritish Journal of Cancer, 1991
- Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factors-αJournal of Photochemistry and Photobiology B: Biology, 1991
- Modulation of hematoporphyrin derivative-sensitized phototherapy with corynebacterium parvum in murine transitional cell carcinomaUrology, 1989
- Cytokine-related immunomodulating activities of an anti-tumor glucan, sizofiran(SPG).Journal of Pharmacobio-Dynamics, 1989
- Release of clotting factors from photosensitized endothelial cells: A possible trigger for blood vessel occlusion by photodynamic therapyFEBS Letters, 1988
- Clinical evaluation of schizophyllan combined with irradiation in patients with cervical cancer: A randomized controlled studyCancer, 1986
- Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cellsCancer Immunology, Immunotherapy, 1984